Literature DB >> 12810306

The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application.

P Loan Honeywell-Nguyen1, H W Wouter Groenink, Anko M de Graaff, Joke A Bouwstra.   

Abstract

In the present study, several aspects of elastic vesicle transport into human skin were investigated in vivo. Surfactant-based elastic vesicles were applied onto human skin in vivo and subsequently a series of tape-strippings were performed, which were visualised by freeze fracture electron microscopy. Factors of investigation for non-occlusive treatment were the duration of application and the volume of application. In addition, occlusive vs. non-occlusive application was studied. The results have shown a fast penetration of intact elastic vesicles into the stratum corneum after non-occlusive treatment, frequently via channel-like regions. Intact vesicles could reach the ninth tape-strip after the 1-h non-occlusive treatment. After the 4-h treatment, vesicle material could be found in the 15th tape-strip. However, micrographs of the 4-h treatment showed extensive vesicle fusion, both at the skin surface as well as in the deeper layers of the stratum corneum. A higher volume of application resulted in an increase in the presence of vesicle material found in the deeper layers of the stratum corneum. Micrographs after occlusive treatment revealed very few intact vesicles in the deeper layers of the stratum corneum, but the presence of lipid plaques was frequently observed. Furthermore, we have proposed a hypothesis that the channel-like regions represent imperfections within the intercellular lipid lamellae in areas with highly undulating cornified envelopes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810306     DOI: 10.1016/s0168-3659(03)00202-5

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

1.  Nanoparticles and their interactions with the dermal barrier.

Authors:  Marc Schneider; Frank Stracke; Steffi Hansen; Ulrich F Schaefer
Journal:  Dermatoendocrinol       Date:  2009-07

2.  Lipid Vesicles for the Skin Delivery of Diclofenac: Cerosomes vs. Other Lipid Suspensions.

Authors:  Anahita Fathi-Azarbayjani; Kai Xin Ng; Yew Weng Chan; Sui Yung Chan
Journal:  Adv Pharm Bull       Date:  2015-03-05

3.  Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations.

Authors:  Suzanne M Bal; Zhi Ding; Gideon F A Kersten; Wim Jiskoot; Joke A Bouwstra
Journal:  Pharm Res       Date:  2010-06-18       Impact factor: 4.200

Review 4.  Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.

Authors:  Pinaki Desai; Ram R Patlolla; Mandip Singh
Journal:  Mol Membr Biol       Date:  2010-10       Impact factor: 2.857

5.  Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations.

Authors:  P Loan Honeywell-Nguyen; Sonia Arenja; Joke A Bouwstra
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

6.  Study of pharmacokinetics and tissue distribution of liposomal brucine for dermal administration.

Authors:  Bai-Can Yang; Zhi-Feng Chu; Sha Zhu; Li-Jun Wang; Yu-Hong Feng; Feng-Hua Li; Chang-Sheng Liu; Yuan Yuan
Journal:  Int J Nanomedicine       Date:  2011-05-26

7.  A new water-based topical carrier with polar skin-lipids.

Authors:  Mats Silvander; Lovisa Ringstad; Ruby Ghadially; Thomas Sköld
Journal:  Lipids Health Dis       Date:  2006-05-03       Impact factor: 3.876

Review 8.  The Challenge of Nanovesicles for Selective Topical Delivery for Acne Treatment: Enhancing Absorption Whilst Avoiding Toxicity.

Authors:  Antonia Mancuso; Maria Chiara Cristiano; Massimo Fresta; Donatella Paolino
Journal:  Int J Nanomedicine       Date:  2020-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.